Printed from ACP-ASIM Online. This is believed to be the first case of its kind. The patient remains free of symptoms two years later. Although this new approach is risky and still highly experimental, it is possible that some people with resistant autoimmune disease may ultimately benefit from this approach. The alleviation of suffering is crucial in all of medicine, especially in the care of the dying.
Physicians can deal more effectively with suffering if they become more expert in diagnosing it.
The author provides guidance on how this can be done.